Ozempic for pets: Everything you need to know
Okava Pharmaceuticals, a biopharmaceutical company, has launched a pilot study of a GLP-1 drug for cats with obesity
Could weight loss drugs be used to treat obese pets?
Experts say roughly six in 10 cats in the U.S. are carrying too much weight. A new clinical trial, “MEOW-1,” could change that, testing to see if GLP-1 weight loss drugs can be used on pets. Ash-har Quraishi reports.
Eli Lilly Cuts Zepbound Price to Widen Access for Obesity Drug
Eli Lilly said on Monday it has lowered the price of single-dose vials of its popular obesity drug Zepbound to make the treatment more affordable for U.S. patients, as… Reuters Health Information
STAT+: New data confirm Novo drug did not slow Alzheimer’s progression
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Good morning. We’ve got a lot of biotech news to get to today. STAT is also launching a 10-part series called “American Science, Shattered” today. You can read the first few stories here. Continue […]
Knownwell Builds A New Model For Obesity Care
Knownwell delivers weight-inclusive primary care and metabolic health treatment as demand for GLP-1 weight-loss drugs grows and telemedicine rules tighten.
Weight loss drugs for cats? Company launches clinical trial of GLP-1 implants in cats – ABC News
Weight loss drugs for cats? Company launches clinical trial of GLP-1 implants in cats ABC News Could Weight Loss Drugs Turn Fat Cats Into Svelte Ozempets? The New York Times Ozempets: will weight-loss jabs for cats and dogs make them miserable? The Guardian ‘MEOW-1’: Could your pet be on weight loss drugs? Company launches clinical trial KOMO Ozempic for […]
GLP‐1 Receptor Agonist Medications for Obesity and Type 2 Diabetes Treatment: A Rapid Review of Changes in Eating Behaviors and Eating Disorder Risk
ABSTRACT This rapid review aimed to evaluate the effects of GLP-1 RAs on eating behaviors and eating disorder risk. Databases were searched to January 2025 to identify studies evaluating GLP-1 RA treatment for adolescents or adults with obesity or Type 2 diabetes. Eligible studies reported adverse events, changes in eating disorder risk, or eating behaviors […]
Details of failed studies cast pall on Novo Nordisk’s GLP-1 as Alzheimer’s treatment – Reuters
Details of failed studies cast pall on Novo Nordisk’s GLP-1 as Alzheimer’s treatment Reuters
A GLP-1 Receptor Agonist Fails to Slow Alzheimer’s Disease in a Phase 3 Trial
On the one hand there is a modest amount of evidence for GLP-1 receptor agonist drugs to produce beneficial effects on an aged metabolism that are unconnected to weight loss. On the other hand, when Big Pharma has a very successful drug, it will attempt to use that drug for every condition it can that […]
Why you could soon have an OzemPET: Test begins on miracle once-a-week shot for obese cats and dogs
As GLP-1 medications like Ozempic have exploded in popularity for humans, researchers from Cornell University are now working on adapting the blockbuster drugs for household pets.